Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Zhejiang Tianyu Pharmaceutical Co., Ltd. (300702.SZ), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
74.61
P/B ratioShare price divided by book value per share.
2.02
P/S ratioMarket value divided by annual revenue.
2.21
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
15.70
EV / RevenueEnterprise value against annual revenue.
2.59
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
1.34%
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
32.36%
Operating marginRevenue left after operating costs.
6.33%
Net marginRevenue left after every cost, including tax and interest.
2.75%
Return on equityProfit as a percentage of shareholders’ equity.
2.37%
Return on assetsProfit as a percentage of total assets.
1.68%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
1.12
Quick ratioThe same, excluding inventory.
0.54
Debt to equityTotal borrowings against shareholders’ equity.
0.53
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$0.28
Book value per shareShareholders’ equity divided by shares outstanding.
$10.33
Shares outstandingShares currently issued.
347,977,159
Market capitalisationShare price times shares outstanding.
$7.27B
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$0
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
24.00%
Payout ratioShare of profit paid out as dividends.
What is Zhejiang Tianyu Pharmaceutical Co., Ltd.'s P/E ratio?
Zhejiang Tianyu Pharmaceutical Co., Ltd. (300702.SZ) trades on a price-to-earnings ratio of 74.61.
What is Zhejiang Tianyu Pharmaceutical Co., Ltd.'s return on equity?
Zhejiang Tianyu Pharmaceutical Co., Ltd. (300702.SZ) reports a return on equity of 2.37%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does Zhejiang Tianyu Pharmaceutical Co., Ltd. carry?
Zhejiang Tianyu Pharmaceutical Co., Ltd. (300702.SZ) has a debt-to-equity ratio of 0.53, which compares total borrowings with shareholders' equity.
What is Zhejiang Tianyu Pharmaceutical Co., Ltd.'s profit margin?
Zhejiang Tianyu Pharmaceutical Co., Ltd. (300702.SZ) keeps 2.75% of revenue as net profit after every cost, including tax and interest.